Full Alliance Group, Inc. (OTCPK: FAGI), Announces Addition of Dr. P Brian Volpp to its Board of Directors

 

Full Alliance Group, Inc. (OTCPK: FAGI), Announces Addition of Dr. P Brian Volpp to its Board of Directors.

Alta Loma, CA -- May 16, 2017 -- InvestorsHub NewsWire -- Full Alliance Group, Inc (OTCPK: FAGI), a multinational holding company, is pleased to announce that Dr P Brian Volpp has been named to its Board of Directors.

Dr. P Brian Volpp, MD, MPH, is currently Medical Director of San Diego Radiosurgery and practices full-time as a board-certified radiation oncologist at various hospitals throughout San Diego County. After graduating cum laude from Princeton University, where he also won the Kellogg and Kafer Trophies as a four-year varsity letter winner on the baseball team, Dr Volpp continued on academically to obtain both his MD as well as an MPH in Administration. He is has published and presented research internationally and is currently primary investigator in a study looking at the role of radiosurgery for treating prostate cancer.

Dr. Volpp also gained board certification by the American Board of Holistic Medicine and is a proponent of integrating alternative medications into conventional Western medicine as he cares for his cancer patients. His immediate task will be to guide management and the advisory board in solidifying its strategic partnership with the Native American tribes in both our bio-dynamic and medicinal cannabis grow businesses. Additionally, He will advise management on current acquisition negotiations that will add multiple revenue producing products to the FAGI's holdings.

“Dr. Volpp’s knowledge and experience in oncology and research, along with his formal business acumen, will be a great contribution in the future of the company as it continues with its reformulation of the neutraceutical line with CBD oil,” said Jacob Thomas, current Chairman of the Board. “His utility should be more substantial looking ahead, however, as the company has targeted several other medically-related projects and acquisitions. Tapping into Dr Volpp’s skill set should prove particularly beneficial to the company during this expansion. We will continue to put together a strong management team that we feel will positively impact shareholder value in both short and long term.”

Jacob Thomas
Chairman of the Board

FORWARD-LOOKING STATEMENTS
 
This shareholder update may contain a number of forward-looking statements. Words and variations of words such as: "expect”, "goals", “could”, "plans", "believe", “continue", "may", "will" and similar expressions are intended to identify our forward-looking statements, including but not limited to: our expectation for growth, benefits from brand-building, cost savings and margins.

These forward-looking statements are subject to a number of risks and uncertainties, many of which are beyond our control, which could cause our actual results to differ materially from those indicated in our forward-looking statements. Such factors include, but are not limited to: continued volatility of, and sharp increase in: costs/pricing actions, increased competition, risks from operating internationally, consumer weakness, weakness in economic conditions and tax law changes.